United States · FDA National Drug Code directory
USTEKINUMAB-TTWE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 82009-160_cb6d8d30-9458-42ed-8aee-2aae13f4760b
- Product NDC
- 82009-160
- Form
- INJECTION, SOLUTION
- Composition / generic term
- ustekinumab-ttwe
- Labeler
- Quallent Pharmaceuticals Health LLC
- Marketing category
- BLA
- Marketing start / end (source format)
- 20250415
- Source listing expiry
- 20271231
Source-listed ingredients
- USTEKINUMAB — 45 mg/.5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE in 1 CARTON (82009-160-11) / .5 mL in 1 SYRINGE · 82009-160-11
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →